The metabolomic quest for a biomarker in chronic kidney disease
- PMID: 30288265
- PMCID: PMC6165760
- DOI: 10.1093/ckj/sfy037
The metabolomic quest for a biomarker in chronic kidney disease
Abstract
Chronic kidney disease (CKD) is a growing burden on people and on healthcare for which the diagnostics are niether disease-specific nor indicative of progression. Biomarkers are sought to enable clinicians to offer more appropriate patient-centred treatments, which could come to fruition by using a metabolomics approach. This mini-review highlights the current literature of metabolomics and CKD, and suggests additional factors that need to be considered in this quest for a biomarker, namely the diet and the gut microbiome, for more meaningful advances to be made.
Keywords: biomarkers; chronic kidney disease; diet; metabolomics.
References
-
- Carrero J-J, Hecking M, Ulasi I. et al. Chronic kidney disease, gender, and access to care: a global perspective. Semin Nephrol 2017; 37: 296–308 - PubMed
-
- Kellum JA, Lameire N, Aspelin P. et al. Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2013; 2: 1–138
-
- NICE. Chronic Kidney Disease in Adults: Assessment and Management | Clinical Guideline [CG182] 2015. https://www.nice.org.uk/guidance/cg182 (28 November 2017, date last accessed)
LinkOut - more resources
Full Text Sources
